SPI Pharma is a global excipient and formulation solutions partner supporting the development and commercialization of innovative drug and vaccine products. We combine high-quality excipients with deep scientific and application expertise to help pharmaceutical companies address complex challenges across oral solid dose, chewables, effervescents, taste-masked systems, parenteral and nutraceutical applications.
Our portfolio includes functional excipients that enhance flow, compression, stability, and bioavailability, as well as well characterized vaccine adjuvants designed to support immune response and formulation performance. Backed by strong regulatory and quality systems, SPI Pharma works collaboratively with development teams to de risk programs, accelerate timelines, and enable patient centric drug delivery solutions.